Concord Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2025 ,inter alia, to consider and approve Standalone and Consolidated ....
CONCORDBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Concord Biotech has informed the stock exchanges that its Board of Directors will meet on Friday, August 8, 2025. The key agenda is to consider and approve the Standalone and Consolidated Unaudited Financial Results for the first quarter ended June 30, 2025, along with the limited review report from the statutory auditors. The company has also reminded that the trading window for insiders remains closed until 48 hours after the results are declared. No financial numbers or business details have been shared in this filing — it is a standard pre-results announcement.
This is a routine regulatory intimation and does not by itself move the stock. Investors should watch for the actual Q1 results on August 8, 2025, which will provide the first read on the company's FY26 performance.